Guardant Health, Inc. Peer Comparison

Metric Value Ranking
Market Cap $5.6 Billion 7/13 TMO
$205.8B		 DHR
$146.0B		 A
$39.4B		 NTRA
$22.7B		 ILMN
$16.4B		 CRL
$7.9B		 GH
$5.6B		 TWST
$2.8B		 CDNA
$1.3B		 MYGN
$1.2B		 CSTL
$780.0M		 PSNL
$331.0M		 NVTA
$5.7M
Gross Margin 100% 1/13 GH
100%		 A
100%		 CSTL
82%		 MYGN
70%		 ILMN
69%		 CDNA
66%		 NTRA
62%		 DHR
59%		 TWST
45%		 TMO
43%		 CRL
35%		 PSNL
34%		 NVTA
32%
Profit Margin -56% 11/13 ILMN
65%		 A
21%		 DHR
17%		 TMO
16%		 CRL
7%		 CSTL
3%		 NTRA
-7%		 CDNA
-9%		 MYGN
-10%		 TWST
-41%		 GH
-56%		 NVTA
-100%		 PSNL
-100%
EBITDA margin -61% 12/13 ILMN
76%		 A
24%		 DHR
22%		 TMO
18%		 CSTL
14%		 CRL
12%		 MYGN
-1%		 NTRA
-9%		 CDNA
-13%		 TWST
-43%		 PSNL
-56%		 GH
-61%		 NVTA
-808%
Quarterly Revenue $191.5 Million 8/13 TMO
$11.4B		 DHR
$6.5B		 A
$1.7B		 ILMN
$1.1B		 CRL
$1.0B		 NTRA
$439.8M		 MYGN
$213.3M		 GH
$191.5M		 NVTA
$121.2M		 CSTL
$85.8M		 TWST
$84.7M		 CDNA
$82.9M		 PSNL
$25.7M
Quarterly Earnings -$107.8 Million 12/13 TMO
$1.8B 		DHR
$1.1B 		ILMN
$705.0M 		A
$351.0M 		CRL
$69.7M 		CSTL
$2.3M 		CDNA
-$7.4M 		MYGN
-$22.1M 		NTRA
-$31.6M 		TWST
-$34.7M 		PSNL
-$39.1M 		GH
-$107.8M 		NVTA
-$942.1M
Quarterly Free Cash Flow -$55.3 Million 9/13 DHR
$1.5B 		ILMN
$284.0M 		CRL
$213.1M 		NTRA
$35.5M 		CSTL
$17.0M 		CDNA
$15.8M 		MYGN
-$5.6M 		PSNL
-$6.4M 		GH
-$55.3M 		NVTA
-$66.9M 		A
-$0 		TMO
-$0 		TWST
-$0
Trailing 4 Quarters Revenue $692.3 Million 8/13 TMO
$42.9B		 DHR
$21.5B		 A
$6.5B		 ILMN
$4.4B		 CRL
$4.1B		 NTRA
$1.5B		 MYGN
$823.6M		 GH
$692.3M		 NVTA
$481.6M		 TWST
$313.0M		 CDNA
$312.8M		 CSTL
$311.9M		 PSNL
$87.5M
Trailing 4 Quarters Earnings -$512.4 Million 11/13 TMO
$11.4B 		DHR
$6.5B 		A
$1.7B 		ILMN
$1.1B 		CRL
$1.0B 		NTRA
$439.8M 		MYGN
$213.3M 		GH
$191.5M 		NVTA
$121.2M 		CSTL
$85.8M 		TWST
$84.7M 		CDNA
$82.9M 		PSNL
$25.7M
Quarterly Earnings Growth -25% 10/13 ILMN
194% 		CSTL
133% 		NTRA
71% 		CDNA
68% 		MYGN
64% 		TWST
25% 		TMO
12% 		DHR
1% 		CRL
-20% 		GH
-25% 		A
-26% 		PSNL
-34% 		NVTA
-213%
Annual Earnings Growth -68% 13/13 CSTL
110% 		NVTA
82% 		MYGN
72% 		A
60% 		NTRA
51% 		CRL
9% 		PSNL
9% 		TWST
4% 		TMO
-6% 		ILMN
-9% 		DHR
-13% 		CDNA
-46% 		GH
-68%
Quarterly Revenue Growth 34% 5/13 DHR
73% 		NTRA
64% 		PSNL
41% 		CSTL
39% 		GH
34% 		TWST
27% 		CDNA
23% 		MYGN
11% 		TMO
5% 		A
1% 		CRL
-2% 		ILMN
-3% 		NVTA
-9%
Annual Revenue Growth 25% 4/13 CSTL
47% 		NTRA
46% 		PSNL
28% 		GH
25% 		TWST
21% 		CDNA
12% 		MYGN
11% 		TMO
1% 		A
-3% 		CRL
-3% 		ILMN
-6% 		NVTA
-11% 		DHR
-12%
Cash On Hand $688.4 Million 6/13 TMO
$4.0B 		DHR
$2.1B 		A
$1.3B 		NTRA
$892.8M 		ILMN
$869.0M 		GH
$688.4M 		TWST
$226.3M 		CRL
$210.2M 		NVTA
$158.0M 		MYGN
$99.9M 		CDNA
$95.4M 		CSTL
$95.0M 		PSNL
$75.8M
Short Term Debt $0 12/13 TMO
$2.2B 		DHR
$505.0M 		NTRA
$80.5M 		ILMN
$73.0M 		A
$45.0M 		NVTA
$21.6M 		TWST
$14.8M 		MYGN
$13.5M 		CDNA
$6.1M 		CRL
$3.2M 		CSTL
$1.7M 		GH
-$0 		PSNL
-$0
Long Term Debt $1.3 Billion 7/13 TMO
$29.1B		 DHR
$15.5B		 A
$3.3B		 CRL
$2.8B		 ILMN
$2.6B		 NVTA
$1.5B		 GH
$1.3B		 NTRA
$385.5M		 MYGN
$129.6M		 TWST
$70.2M		 PSNL
$35.6M		 CSTL
$25.0M		 CDNA
$23.8M
PE -1.00 6/13 CSTL
128.40		 DHR
37.45		 TMO
32.48		 A
30.56		 CRL
19.02		 GH
-1.00		 CDNA
-1.00		 ILMN
-1.00		 NVTA
-1.00		 MYGN
-1.00		 NTRA
-1.00		 PSNL
-1.00		 TWST
-1.00
PS 8.10 3/13 NTRA
14.82		 TWST
8.81		 GH
8.10		 DHR
6.80		 A
6.05		 TMO
4.80		 CDNA
4.11		 PSNL
3.78		 ILMN
3.74		 CSTL
2.50		 CRL
1.94		 MYGN
1.45		 NVTA
0.01
PB 0.00 12/13 NTRA
25.84		 ILMN
6.74		 A
6.68		 TWST
5.83		 CDNA
4.70		 TMO
4.15		 DHR
2.95		 CRL
2.06		 PSNL
1.98		 CSTL
1.77		 MYGN
1.63		 GH
0.00		 NVTA
0.00
PC 8.15 11/13 DHR
70.27		 TMO
51.33		 CRL
37.47		 A
29.64		 NTRA
25.43		 ILMN
18.90		 CDNA
13.47		 TWST
12.18		 MYGN
11.93		 CSTL
8.21		 GH
8.15		 PSNL
4.37		 NVTA
0.04
Liabilities to Equity 0.00 12/13 ILMN
1.47		 CRL
1.10		 A
1.01		 TMO
0.96		 NTRA
0.81		 CDNA
0.75		 DHR
0.57		 MYGN
0.48		 PSNL
0.44		 TWST
0.30		 CSTL
0.17		 GH
0.00		 NVTA
0.00
ROA -0.33 10/13 A
11% 		TMO
7% 		DHR
5% 		CRL
5% 		CSTL
1% 		MYGN
-11% 		NTRA
-13% 		ILMN
-26% 		CDNA
-30% 		GH
-33% 		TWST
-34% 		PSNL
-38% 		NVTA
-269%
ROE 8.53 1/13 GH
853% 		NVTA
133% 		A
22% 		TMO
13% 		CRL
11% 		DHR
8% 		CSTL
1% 		MYGN
-16% 		NTRA
-24% 		TWST
-44% 		CDNA
-53% 		PSNL
-55% 		ILMN
-65%
Current Ratio 0.96 12/13 CSTL
7.00		 TWST
4.34		 PSNL
3.28		 MYGN
3.09		 DHR
2.77		 CDNA
2.34		 NTRA
2.23		 TMO
2.04		 A
1.99		 CRL
1.92		 ILMN
1.68		 GH
0.96		 NVTA
0.33
Quick Ratio 0.62 6/13 CSTL
128.40		 DHR
37.45		 TMO
32.48		 A
30.56		 CRL
19.02		 GH
-1.00		 CDNA
-1.00		 ILMN
-1.00		 NVTA
-1.00		 MYGN
-1.00		 NTRA
-1.00		 PSNL
-1.00		 TWST
-1.00
Long Term Debt to Equity -21.83 13/13 ILMN}
1.07		 CRL}
0.73		 TMO}
0.59		 A}
0.57		 NTRA}
0.44		 DHR}
0.31		 PSNL}
0.21		 MYGN}
0.18		 TWST}
0.15		 CDNA}
0.09		 CSTL}
0.06		 NVTA}
-1.37		 GH}
-21.83
Debt to Equity -21.83 13/13 ILMN
1.07		 CRL
0.73		 TMO
0.63		 A
0.57		 NTRA
0.53		 DHR
0.32		 PSNL
0.21		 MYGN
0.20		 TWST
0.18		 CDNA
0.09		 CSTL
0.06		 NVTA
-1.39		 GH
-21.83
Burn Rate 4.30 5/13 NTRA
13.30		 CDNA
9.64		 TWST
5.50		 CRL
5.06		 GH
4.30		 MYGN
3.26		 PSNL
1.87		 NVTA
0.16		 ILMN
-1.49		 DHR
-6.12		 A
-6.45		 TMO
-35.15		 CSTL
-114.00
Cash to Cap 0.12 3/13 NVTA
27.58		 PSNL
0.23		 GH
0.12		 CSTL
0.12		 MYGN
0.08		 TWST
0.08		 CDNA
0.07		 ILMN
0.05		 NTRA
0.04		 A
0.03		 CRL
0.03		 TMO
0.02		 DHR
0.01
CCR 0.51 4/13 CSTL
7.47		 CRL
3.06		 DHR
1.38		 GH
0.51		 ILMN
0.40		 MYGN
0.25		 PSNL
0.16		 NVTA
0.07		 NTRA
-1.12		 CDNA
-2.13		 A
 TMO
 TWST
EV to EBITDA -53.10 9/13 TMO}
115.60		 DHR}
112.25		 A}
101.60		 CRL}
88.79		 CSTL}
59.20		 ILMN}
21.98		 NVTA}
-1.38		 PSNL}
-20.22		 GH}
-53.10		 TWST}
-72.54		 CDNA}
-115.66		 MYGN}
-561.30		 NTRA}
-566.22
EV to Revenue 9.00 2/13 NTRA
14.54		 GH
9.00		 TWST
8.35		 DHR
7.45		 A
6.37		 TMO
5.44		 ILMN
4.14		 CDNA
3.88		 PSNL
3.32		 NVTA
2.82		 CRL
2.57		 CSTL
2.28		 MYGN
1.50

Cookies

We use cookies to offer a better browsing experience. Cookies enhance site navigation, analyze site usage, and assist in our marketing efforts. By clicking Accept. you agree to the storing of cookies on your device. To refuse all non-required cookies, click on Decline.

Accept View Terms & Conditions